Researchers from Monell Chemical Senses Center have identified a specific population of neurons in the brain that could be key for appetite suppression with GLP-1 drugs without nausea
Ingredient disclosure: Brand describes a "proprietary blend of GLP-1-supporting botanicals" - no specific ingredients listed on the official site as of June 2026
Keywords: GLP-1 receptor agonists, GLP-1/GIP dual receptor agonists, incretin mimetics, gastric emptying, tachyphylaxis, retained gastric content, aspiration Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) and the dual incretin receptor agonist tirzepatide have a major, and increasing, impact on the current management of type 2 diabetes (T2D) and obesity
Data Sheet Application: Research on metabolism, obesity, fatty liver disease, exercise performance, inflammation, neuroprotection, and cardiovascular disease